Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Cowen and Company Reaffirms “Buy” Rating for Trupanion Inc (NYSE:TRUP)
Get Analysts' Upgrades and Downgrades Daily
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
A number of other equities analysts have also commented on TRUP. Northland Securities set a $23.00 price objective on Trupanion and gave the stock a buy rating in a research note on Thursday, July 6th. ValuEngine upgraded Trupanion from a sell rating to a hold rating in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Trupanion currently has an average rating of Buy and an average target price of $19.14.
Shares of Trupanion (TRUP) traded down 0.18% on Friday, reaching $22.65. The company had a trading volume of 73,112 shares. Trupanion has a 52-week low of $13.71 and a 52-week high of $23.89. The firm’s market capitalization is $674.06 million. The company has a 50-day moving average price of $19.88 and a 200-day moving average price of $16.54.
WARNING: This news story was first posted by [[site]] and is owned by of [[site]]. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at [[permalink]].
In related news, major shareholder General Partner Ll Maveron III sold 6,083 shares of Trupanion stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $16.89, for a total transaction of $102,741.87. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $22.20, for a total value of $77,700.00. Following the sale, the insider now directly owns 1,463,505 shares in the company, valued at $32,489,811. The disclosure for this sale can be found here. Insiders sold 23,583 shares of company stock worth $440,142 over the last quarter.
A number of large investors have recently added to or reduced their stakes in the company. American International Group Inc. increased its stake in Trupanion by 7.1% in the first quarter. American International Group Inc. now owns 8,864 shares of the financial services provider’s stock worth $126,000 after buying an additional 588 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Trupanion during the first quarter worth $194,000. Bank of Montreal Can increased its stake in Trupanion by 309.2% in the second quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock worth $201,000 after buying an additional 6,834 shares during the period. Alliancebernstein L.P. increased its stake in Trupanion by 1.2% in the first quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock worth $237,000 after buying an additional 200 shares during the period. Finally, AQR Capital Management LLC increased its stake in Trupanion by 0.3% in the fourth quarter. AQR Capital Management LLC now owns 22,264 shares of the financial services provider’s stock worth $346,000 after buying an additional 73 shares during the period.
About Trupanion
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.